dual gip/glp-1 receptor agonist Understand GLP-1/GIP Tirzepatide and Its Effect on Current Weight Loss Therapy The Effects of Dual GLP-1/GIP

Wander PL, Lowy E, Beste LA, Tulloch-Palomino L, Korpak A, et al

has received research funding from NHMRC, Diabetes Australia, Novartis, and Sanofi

Well, it turns out these creepy deep sea monsters have an entire organ for making glucagon, and it was just much easier to dissect that organ out than it was to painstakingly pluck the tiny number of glucagon making cells out of like a mouse's pancreas

As research in this field continues to evolve, ongoing and future CVOTs will likely expand our knowledge of the cardiovascular benefits of GLP-1 receptor agonists, ultimately improving the care and outcomes of individuals with T2D and CVD

Interestingly, in a recent post hoc study, further analysis of plasma samples from this trial revealed that tirzepatide dose-dependently lowered triglyceride, apoC-III, and apoB levels over time and reduced the number of large triglyceride-rich lipoprotein particles and small low-density lipoprotein particles compared to dulaglutide and/or placebo [86]

In Colorectal cancer, Ma et al